Novartis AG Price Today
Novartis AG
NVS
Healthcare
$215.78B
💰
Market Cap
28.3
💸
Price to Earnings
$3.6
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
10 |
Strong Buy |
7 |
Hold |
12 |
Sell |
2 |
Strong Sell |
0 |
NVS Price Forecast Target
101.8 👉 124.0 +22%
NVS EPS Forecast
3.6 👉 7.5 +109%
Financials
Profit Margin
14 %
Revenue Growth
6.5 %
Dividend
$ 3.5
Held Percent
0.0% - Insiders
8.0% - Institutions
92.0% - Public
Major Fund Holders
-
💰 Dodge & Cox Inc $1.9B
-
💰 Primecap Management Company $1.5B
-
💰 Envestnet Asset Management $778.5M
-
💰 Bank of America Corporation $699.6M
-
💰 Franklin Resources, Inc. $642.4M
Stock Ideas
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …
Daniel Sundheim Portfolio
Daniel Sundheim is the founder of D1 Capital Partners, a renowned multi-billion dollar global investment firm. Prior to starting his own firm, Sundheim worked as a portfolio manager at prestigious hedge funds before breaking out on his own in 2018. …
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…
Chase Coleman Portfolio
Chase Coleman, the young and accomplished founder of Tiger Global, has made a significant impact in the investment world. With initial funding from Julian Robertson, Coleman's Tiger Global Management delivered impressive returns, including a remarka…📮FAQ
Some Frequently Asked Questions.
The Novartis AG industry is Drug Manufacturers—General
The Novartis AG sector is Healthcare
The Novartis AG forecasted predicted Price to Earnings PE ratio is 13.5
The Novartis AG Price to Earnings PE ratio is 28.3
The Market Capitalization of Novartis AG is $215.78B
There are total of 19767842532 float shares with 8.0% held by Institutions and 0.0% held by insiders
The MNovartis AG forecasted Earnings per Share EPS is $7.5
The Novartis AG Earnings per Share EPS is 3.6
The Novartis AG company has $36744000000 gross profits with 14 profit margins
The Novartis AG Earnings Growth is 0.442% with 0.367% quarterly earnings growth
The Novartis AG Revenue is $53072998400 with 0.065 revenue growth
The price target for Novartis AG stock is $124.0 for the high target and $105.0 for the low target
The consensus analyst recommendations for Novartis AG is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Novartis AG is Buy, with the following breakdown:
- Buy: 10
- Strong Buy: 7
- Hold: 12
- Sell: 2
- Strong Sell: 0
The Beta of Novartis AG is 0.5
The dividend of Novartis AG is $3.5
The dividend yield of Novartis AG is 0.0344%
The biggest institutional and mutual fund holders of Novartis AG stock are
- Dodge & Cox Inc
- Primecap Management Company
- Envestnet Asset Management
- Bank of America Corporation
The Novartis AG ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0